Loading
What changed between revision 1 and revision 2, compared over the article's markdown source with its frontmatter — so a change to status, evidence or reversibility shows up as the edit it is.
Older · revision 1
Import· initial corpus import, not an edit
Initial import of content/asilomar-conference.md — the filesystem corpus, unchanged. Not an edit.
13.6 kB
Revision 1
Revision 2
lines 7–14 → 7–136 unchanged lines not shown
categories: ["genetics", "society"]categories: ["genetics", "society"]tags: ["governance", "biosafety", "recombinant dna", "self-regulation", "moratorium", "history of science"]tags: ["governance", "biosafety", "recombinant dna", "self-regulation", "moratorium", "history of science"]summary: "The 1975 meeting at which molecular biologists lifted their own moratorium on recombinant DNA work by agreeing a system of physical and biological containment."summary: "The 1975 meeting at which molecular biologists lifted their own moratorium on recombinant DNA work by agreeing a system of physical and biological containment."updated: "2026-07-27"updated: "2026-08-23"issues: ["The Cambridge citizens review board and the failed late-1970s US bills are described without sources."]------ ```infobox```infoboxlines 26–32 → 25–3111 unchanged lines not shown
}}`````` The **Asilomar Conference on Recombinant DNA** was a four-day meeting of about 140 scientists, lawyers, and journalists held in February 1975 at a conference ground on the California coast, convened to decide whether and how experiments splicing DNA between species should resume. Its participants had imposed a voluntary moratorium on themselves the previous year; at Asilomar they lifted it, replacing prohibition with a graded system of laboratory containment. The meeting is invoked, half a century later, as the template for scientific self-governance — including in the debates over [[germline-editing]] — and the accuracy of that analogy is itself contested.The **Asilomar Conference on Recombinant DNA** was a four-day meeting of about 140 scientists, lawyers, and journalists held in February 1975 at a conference ground on the California coast, convened to decide whether and how experiments splicing DNA between species should resume. Its participants had imposed a voluntary moratorium on themselves the previous year; at Asilomar they lifted it, replacing prohibition with a graded system of laboratory containment. The meeting is invoked, half a century later, as the template for scientific self-governance — including in the debates over [[germline-editing]] — and the accuracy of that analogy is itself contested. In February 2025 a summit returned to the same conference grounds for the fiftieth anniversary, and closed by publishing a set of signed entreaties rather than a single agreed framework.[^asilomar2025] ## Background## Background lines 69–81 → 68–8036 unchanged lines not shown
The National Institutes of Health issued formal guidelines in 1976 that codified the Asilomar framework for federally funded work, enforced through institutional biosafety committees and administered with advice from the Recombinant DNA Advisory Committee. Over the following six years the guidelines were progressively relaxed as the feared hazards failed to materialise.The National Institutes of Health issued formal guidelines in 1976 that codified the Asilomar framework for federally funded work, enforced through institutional biosafety committees and administered with advice from the Recombinant DNA Advisory Committee. Over the following six years the guidelines were progressively relaxed as the feared hazards failed to materialise. Public reaction was not uniformly deferential. The city council of Cambridge, Massachusetts imposed a local moratorium in 1976 and convened a review board of ordinary citizens — a machinist, a nurse, a nun among them — which after months of hearings recommended permitting the research under the NIH guidelines with additional local conditions. The episode is cited by both sides: as evidence that non-specialists can adjudicate technical controversy responsibly, and as evidence that they will generally arrive where the scientists were already standing.Public reaction was not uniformly deferential. The city council of Cambridge, Massachusetts imposed a local moratorium in 1976 and convened a review board of ordinary citizens — a machinist, a nurse, a nun among them — which after months of hearings recommended permitting the research under the NIH guidelines with additional local conditions.[^krimsky1982] The episode is cited by both sides: as evidence that non-specialists can adjudicate technical controversy responsibly, and as evidence that they will generally arrive where the scientists were already standing. Commercial biotechnology arrived immediately afterwards. Genentech was founded in 1976, and within a few years recombinant insulin was in production. Asilomar took place in the last moment when the field had no industry, no share prices, and no patents at stake, which is one reason its participants could agree to stop. The advisory committee it inspired went on to review individual [[somatic-gene-therapy]] protocols for three decades. The fourteen-day limit on culturing human embryos, agreed by advisory bodies in the years that followed and now under pressure from [[synthetic-embryos|stem-cell-based embryo models]], is the other durable example of a research boundary that scientists drew around themselves.Commercial biotechnology arrived immediately afterwards. Genentech was founded in 1976, and within a few years recombinant insulin was in production. Asilomar took place in the last moment when the field had no industry, no share prices, and no patents at stake, which is one reason its participants could agree to stop. The advisory committee it inspired went on to review individual [[somatic-gene-therapy]] protocols for three decades. The fourteen-day limit on culturing human embryos, agreed by advisory bodies in the years that followed and now under pressure from [[synthetic-embryos|stem-cell-based embryo models]], is the other durable example of a research boundary that scientists drew around themselves. ## Criticism## Criticism Historians of the controversy have argued that the meeting's narrow framing was its central political act rather than an incidental feature. By defining the question as biohazard containment, the participants placed it inside their own expertise and outside anyone else's; questions about who should benefit, who bears risk, and whether some applications should exist at all were ruled off-topic and never reinstated.[^krimsky1982][^wright1994] On this reading Asilomar succeeded in its unstated purpose, which was to forestall statutory regulation by demonstrating that the field could police itself. Several bills to regulate recombinant DNA were introduced in the US Congress in the late 1970s; none passed.Historians of the controversy have argued that the meeting's narrow framing was its central political act rather than an incidental feature. By defining the question as biohazard containment, the participants placed it inside their own expertise and outside anyone else's; questions about who should benefit, who bears risk, and whether some applications should exist at all were ruled off-topic and never reinstated.[^krimsky1982][^wright1994] On this reading Asilomar succeeded in its unstated purpose, which was to forestall statutory regulation by demonstrating that the field could police itself. Several bills to regulate recombinant DNA were introduced in the US Congress in the late 1970s; none passed, and the controls that did exist were progressively dismantled over the years that followed.[^wright1994] A second criticism concerns who was in the room. Every substantive participant was a researcher. No patients, no workers who would handle the organisms, no members of affected publics took part. The later observation that Asilomar established scientists as the arbiters of which questions count has been developed by scholars examining its use as a precedent for genome editing.[^hurlbut2015]A second criticism concerns who was in the room. Every substantive participant was a researcher. No patients, no workers who would handle the organisms, no members of affected publics took part. The later observation that Asilomar established scientists as the arbiters of which questions count has been developed by scholars examining its use as a precedent for genome editing.[^hurlbut2015] lines 85–95 → 84–943 unchanged lines not shown
The question is different in kind. Whether an enfeebled bacterium can survive in a gut is an empirical matter on which molecular biologists have genuine authority. Whether it is acceptable to alter the genome of a person who does not yet exist is a question of value on which they have none, and Asilomar's precedent of scientists deciding the scope of the debate is, in that setting, part of the problem rather than the solution.The question is different in kind. Whether an enfeebled bacterium can survive in a gut is an empirical matter on which molecular biologists have genuine authority. Whether it is acceptable to alter the genome of a person who does not yet exist is a question of value on which they have none, and Asilomar's precedent of scientists deciding the scope of the debate is, in that setting, part of the problem rather than the solution. The community is different. In 1975 recombinant DNA work required rare reagents, rare skills, and a handful of laboratories whose leaders all knew one another. Editing an embryo in 2026 requires equipment available in any IVF clinic and reagents that can be ordered online, distributed across thousands of institutions in dozens of legal jurisdictions — to say nothing of the amateur culture described under [[biohacking]]. A norm agreed by a professional community binds only its members, as the [[he-jiankui-affair]] demonstrated and as privately funded ventures continue to demonstrate.The community is different. In 1975 recombinant DNA work required rare reagents, rare skills, and a handful of laboratories whose leaders all knew one another. Embryo editing draws on capability that is far more widely distributed — across many institutions and many legal jurisdictions, to say nothing of the amateur culture described under [[biohacking]]. A norm agreed by a professional community binds only its members, as the [[he-jiankui-affair]] demonstrated. The moratorium was different. Asilomar's applied to experiments, was expected to be temporary, and lasted less than a year. Proposals for germline moratoria concern applications and are open-ended, which makes them harder to sustain and easier to defect from.The moratorium was different. Asilomar's applied to experiments, was expected to be temporary, and lasted less than a year. Proposals for germline moratoria concern applications and are open-ended, which makes them harder to sustain and easier to defect from. Finally, the stakes are structurally different. A containment failure in 1975 would have been an accident with victims and a remedy. A heritable edit is transmitted to descendants who cannot consent and cannot be restored, which is why the frameworks discussed in [[governance-of-genome-editing]] reach for law rather than professional agreement, and why arguments from the [[precautionary-principle]] and from [[differential-technological-development]] have more traction here than they did in 1975. Whether any equivalent of the 1974 letter could command the same compliance today has not been tested, and there is little reason for confidence that it would.Finally, the stakes are structurally different. A containment failure in 1975 would have been an accident with victims and a remedy. A heritable edit is transmitted to descendants who cannot consent and cannot be restored, which is why the frameworks discussed in [[governance-of-genome-editing]] reach for law rather than professional agreement. The organising committee of the third international summit on human genome editing reported in 2023 that heritable editing remained unacceptable because neither the governance frameworks nor the safety standards for it were in place — a professional body describing, half a century after Asilomar, the limits of what professional bodies can settle.[^summit2023] Arguments from the [[precautionary-principle]] and from [[differential-technological-development]] also have more traction here than they did in 1975. Whether any equivalent of the 1974 letter could command the same compliance today has not been tested, and there is little reason for confidence that it would. ## See also## See also lines 110–113 → 109–11414 unchanged lines not shown
[^wright1994]: `book` Wright, S. *Molecular Politics: Developing American and British Regulatory Policy for Genetic Engineering, 1972–1982*. University of Chicago Press, 1994.[^wright1994]: `book` Wright, S. *Molecular Politics: Developing American and British Regulatory Policy for Genetic Engineering, 1972–1982*. University of Chicago Press, 1994.[^hurlbut2015]: `paper` Hurlbut, J.B. "Limits of Responsibility: Genome Editing, Asilomar, and the Politics of Deliberation." *Hastings Center Report*, 2015.[^hurlbut2015]: `paper` Hurlbut, J.B. "Limits of Responsibility: Genome Editing, Asilomar, and the Politics of Deliberation." *Hastings Center Report*, 2015.[^baltimore2015]: `paper` Baltimore, D. et al. "A prudent path forward for genomic engineering and germline gene modification." *Science*, 2015. {A position piece by a group including Baltimore and Berg of the 1975 organising committee; it recommends a pause and carries no legal force.}[^baltimore2015]: `paper` Baltimore, D. et al. "A prudent path forward for genomic engineering and germline gene modification." *Science*, 2015. {A position piece by a group including Baltimore and Berg of the 1975 organising committee; it recommends a pause and carries no legal force.}[^summit2023]: `statement` Organising Committee of the Third International Summit on Human Genome Editing. "Statement from the Organising Committee." London, March 2023. {A summary of the organisers' conclusions from a three-day meeting, not a consensus report reviewed by the convening academies.}[^asilomar2025]: `statement` "The Spirit of Asilomar and the Future of Biotechnology." Summit held at the Asilomar Conference Grounds, Pacific Grove, California, 23–26 February 2025; entreaties archived by Rice University. {The meeting produced signed entreaties from participating groups rather than a single agreed statement, which is itself the contrast with 1975.} removed, struck through added, underlinedLine numbers count the serialised markdown of each revision, frontmatter included.
106 lines are the same in both revisions, and 70 of them are not shown. Neither revision here is necessarily the current article — read Asilomar Conference on Recombinant DNA for the text this wiki stands behind today.